Please login to the form below

Not currently logged in
Email:
Password:

Jivi

This page shows the latest Jivi news and features for those working in and with pharma, biotech and healthcare.

Sobi shows strong growth despite haemophilia competition

Sobi shows strong growth despite haemophilia competition

Another new entrant in the haemophilia A market is Bayer’s Jivi, which has a twice weekly dosing schedule. ... Hemlibra and Jivi are starting to make inroads into the wider haemophilia market in Europe, but Sobi remains confident that Elocta can also

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...
Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...